“We’re pleased to bring this product to market for the customers and patients who will benefit from access to this medicine and who have in the past experienced supply disruptions in the market place,” said Marc Kikuchi, CEO, North America Generics, Dr Reddy’… Read More

reported by at Moneycontrol.com